http://www.iacfsme.org/LinkClick.aspx?fileticket=EFIrm+uCnkM=&tabid=142
In page 46 is an interesting work of Shoemaker with VIP .
They had a symptom reduction in all patients with not adverse effects.
The VIP was administered intranasally four times a day.
"Treatmet with VPI restored clinical functioning in a cohort of patients with severe CFS illnes".
I dont know if this is a very expensive treatment,but I hope can be a good treatment in the future.
In page 46 is an interesting work of Shoemaker with VIP .
They had a symptom reduction in all patients with not adverse effects.
The VIP was administered intranasally four times a day.
"Treatmet with VPI restored clinical functioning in a cohort of patients with severe CFS illnes".
I dont know if this is a very expensive treatment,but I hope can be a good treatment in the future.